<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">A very limited dosage of methylprednisolone (1–2 mg/kg/day) has been suggested to alleviate the symptoms like acute respiratory distress and lung inflammation (Huang et al. 
 <xref ref-type="bibr" rid="CR18">2020</xref>). Although corticosteroids were found to reduce inflammation in lungs due to SARS-CoV studies had also reported delay in viral clearance due to corticosteroids. Recombinant IFN along with Ribavirin is also being administered to 2019-CoV patients, but the treatment is not very effective (Chen et al. 
 <xref ref-type="bibr" rid="CR7">2020b</xref>).
</p>
